Literature DB >> 32132810

Triglycerides and Cardiovascular Outcomes-Can We REDUCE-IT ?

Akshyaya Pradhan1, Monika Bhandari1, Pravesh Vishwakarma1, Rishi Sethi1.   

Abstract

The causal linkage between triglycerides and coronary artery disease has been controversial. Most of the trials hitherto have shown marginal or no beneficial effects of reduction of triglycerides (with fibrates) on top of low-density lipoprotein (LDL) reduction. But a significant residual cardiovascular risk remains even after use of high dose of statins. Omega-3 fatty acids have been shown to reduce triglyceride levels and some old trials have shown the benefits of fish oils in reducing cardiovascular events. However, barring a few trials most of the large trials of omega-3 fatty acids are negative. Recently, few large trials have been conducted to see the effects of high dose omega-3 fatty acids on cardiovascular outcomes and some of them have shown promising results on top of LDL reduction. © Thieme Medical Publishers.

Entities:  

Keywords:  cardiovascular disease; omega-3 fatty acids; statins; triglycerides

Year:  2020        PMID: 32132810      PMCID: PMC7054063          DOI: 10.1055/s-0040-1701639

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  58 in total

1.  n-3 fatty acids and cardiovascular events after myocardial infarction.

Authors:  Daan Kromhout; Erik J Giltay; Johanna M Geleijnse
Journal:  N Engl J Med       Date:  2010-08-28       Impact factor: 91.245

2.  Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.

Authors:  V Manninen; L Tenkanen; P Koskinen; J K Huttunen; M Mänttäri; O P Heinonen; M H Frick
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

3.  Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Authors:  Christopher P Cannon; Michael A Blazing; Robert P Giugliano; Amy McCagg; Jennifer A White; Pierre Theroux; Harald Darius; Basil S Lewis; Ton Oude Ophuis; J Wouter Jukema; Gaetano M De Ferrari; Witold Ruzyllo; Paul De Lucca; KyungAh Im; Erin A Bohula; Craig Reist; Stephen D Wiviott; Andrew M Tershakovec; Thomas A Musliner; Eugene Braunwald; Robert M Califf
Journal:  N Engl J Med       Date:  2015-06-03       Impact factor: 91.245

4.  The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.

Authors:  Joann E Manson; Shari S Bassuk; I-Min Lee; Nancy R Cook; Michelle A Albert; David Gordon; Elaine Zaharris; Jean G Macfadyen; Eleanor Danielson; Jennifer Lin; Shumin M Zhang; Julie E Buring
Journal:  Contemp Clin Trials       Date:  2011-10-02       Impact factor: 2.226

5.  Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease.

Authors:  S B Hulley; R H Rosenman; R D Bawol; R J Brand
Journal:  N Engl J Med       Date:  1980-06-19       Impact factor: 91.245

6.  Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.

Authors:  Prakash Deedwania; Philip Barter; Rafael Carmena; Jean-Charles Fruchart; Scott M Grundy; Steven Haffner; John J P Kastelein; John C LaRosa; Holly Schachner; James Shepherd; David D Waters
Journal:  Lancet       Date:  2006-09-09       Impact factor: 79.321

7.  Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.

Authors:  M Laakso; S Lehto; I Penttilä; K Pyörälä
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

8.  The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

Authors:  Cynthia J Girman; Thomas Rhodes; Michele Mercuri; Kalevi Pyörälä; John Kjekshus; Terje R Pedersen; Polly A Beere; Antonio M Gotto; Michael Clearfield
Journal:  Am J Cardiol       Date:  2004-01-15       Impact factor: 2.778

9.  Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.

Authors:  Theingi Aung; Jim Halsey; Daan Kromhout; Hertzel C Gerstein; Roberto Marchioli; Luigi Tavazzi; Johanna M Geleijnse; Bernhard Rauch; Andrew Ness; Pilar Galan; Emily Y Chew; Jackie Bosch; Rory Collins; Sarah Lewington; Jane Armitage; Robert Clarke
Journal:  JAMA Cardiol       Date:  2018-03-01       Impact factor: 14.676

10.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.